Conduct of Clinical Trials: Asia Pacific Region Versus Global
Main Article Content
Abstract
Conducting clinical trials , this process is time-consuming and complicated, which required substantial investment. Pharmaceutical and biotechnology companies and in the Europe and United States (US) face escalating clinical trial challenges and cost in both retaining and recruiting patients. Additionally, sponsor pharmaceutical companies have to face complex regulation and continuously evolving regulatory processes. Due to these complication and, US and European biotechnology and pharmaceutical companies outsource their clinical studies to Asia pacific region. This article draw a special attention to the research on increasing trend in conducting clinical trials in Asia pacific region and worldwide.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Author(s) and co-author(s) jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere. Author(s) agree to the terms that the IJRDO Journal will have the full right to remove the published article on any misconduct found in the published article.
References
2 National Institutes of Health, ClinicalTrials.gov website, clinicaltrials.gov/ct2/search/map, accessed Nov 4, 2013.
3 C. Toller, Journal for Clinical Studies 5 (3) 20-23 (2013).
4 Global Clinical Trials in Asia: Challenges and Opportunities, May 2010 http://www.diaglobal. org/productfiles/22993/day%203/402/s402%2001_vijay%20prabhakar.pdf
5 Lee YJ, Clinical Trials in Korea: Why Korea? Seoul: LSK Global Pharma Services, 2010. Available from: http://lskglobal.com/pdf/Why%20Korea.pdf. Accesssed April 8, 2013.